Muconasal Plus (Tramazoline Hydrochloride Monohydrate)

Tramazoline hydrochloride, the active ingredient in Muconasal Plus, is a decongestant presented as a nasal formulation for intranasal use. It relieves nasal congestion associated with rhinitis and other upper‑respiratory conditions by reducing swelling of the nasal mucosa. GNH USA supplies Muconasal Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

GNH USA supplies Muconasal Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Muconasal Plus, a nasal decongestant, is used to alleviate symptoms within the upper‑respiratory tract where nasal swelling occurs.

- Nasal congestion: reduces blockage and improves airflow in the nasal passages. - Allergic rhinitis: diminishes swelling and congestion caused by allergic inflammation. - Non‑allergic rhinitis: eases congestion associated with irritant‑induced nasal inflammation.

Tramazoline hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation. - Sneezing. - Dryness of the nasal mucosa. - Mild headache. - Transient epistaxis (nosebleed). - Taste disturbance.

Serious or Rare Side Effects: - Severe hypertension. - Cardiac arrhythmias. - Allergic reactions such as rash, itching, or angioedema. - Persistent nasal ulceration. - Vision changes due to ocular vasoconstriction. - Rebound congestion with prolonged use.

Before using Muconasal Plus, consider the following safety measures.

- Cardiovascular disease: avoid use in uncontrolled hypertension or heart disease. - Pregnancy and lactation: consult a healthcare professional before use. - Age restrictions: not recommended for children under the age specified by the prescriber. - Concomitant nasal medications: avoid simultaneous use with other vasoconstrictive nasal sprays. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Tramazoline hydrochloride may interact with other agents that affect vascular tone or blood pressure.

Major Interactions (Avoid):\n- Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Systemic sympathomimetics: additive vasoconstrictive effects. - Nasal decongestant combinations: increased risk of rebound congestion.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs: may reduce their efficacy. - Anticoagulants: potential for increased nasal bleeding. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may exacerbate nasal irritation.